GENinCode Plc: FDA Pre-Submission Filed for Cardio inCode-SC

Commencement of regulatory pathway for U.S. market approvalOXFORD, England, Jan. 11, 2022Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces

Related Keywords

United States , United Kingdom , Genincode Plcis , Paul Foulger , Drug Administration , Genincode Us Inc , Genincode Plc , Code Plc , Code Plcis , United Kingdom Based , Genincode , Submission , Iled , Cardio , Fancode , Core ,